[Treatment of anxiety with bromazepam in clinical practice (author's transl)]. 1982

S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon

In this co-operative study 50 patients of both sexes, aged from 18 to 66 years and suffering from neurotic anxiety with functional symptoms were treated with bromazepam (Lexomil) alone for 28 days. With daily doses averaging 6 to 9 mg, good or excellent results were obtained in 78% of the cases, including 58% of somatic cures. Assessment of the anxiety, carried out on days 0, 14 and 28 with the Pull-Guelfi and Hamilton scales, showed optimal response on the 14 th day of treatment in ambulatory patients. Side-effects mostly consisted of sedation which regressed spontaneously or after dosage was reduced.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D001960 Bromazepam One of the BENZODIAZEPINES that is used in the treatment of ANXIETY DISORDERS. Anxyrex,Apo-Bromazepam,BromaLich,Bromaz 1A Pharma,Bromazanil,Bromazep Von Ct,Bromazepam AL,Bromazepam Beta,Bromazepam Heumann,Bromazepam-Neuraxpharm,Bromazepam-Ratiopharm,Durazanil,Gen-Bromazepam,Lexatin,Lexomil,Lexotan,Lexotanil,Ro 5-3350,Apo Bromazepam,Beta, Bromazepam,Bromazepam Neuraxpharm,Bromazepam Ratiopharm,Gen Bromazepam,Ro 53350,Von Ct, Bromazep
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
S Bornstein, and H Benoudich, and E Kaufman, and M Konqui, and P Pigeon
May 1982, La Nouvelle presse medicale,
Copied contents to your clipboard!